Partnership for Part D Access
  • Home
  • The Issue
    • Six Protected Classes
    • History
    • Patient Communities
  • The People
    • Clinician Advisory Board
    • Community Perspectives
    • From the Community
  • The Resources
    • Resource Library
    • Video Library
  • The Newsroom
  • About Us
    • Who We Are
    • Our Leadership
    • Contact Us
  • Home
  • The Issue
    • Six Protected Classes
    • History
    • Patient Communities
  • The People
    • Clinician Advisory Board
    • Community Perspectives
    • From the Community
  • The Resources
    • Resource Library
    • Video Library
  • The Newsroom
  • About Us
    • Who We Are
    • Our Leadership
    • Contact Us

Newsroom​ 

Sens. Rubio, Sinema Lead Letter Defending Medicare's Six Protected Classes

3/13/2019

1 Comment

 
Picture
​In a letter to Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma, a bipartisan group of 14 Senators — led by Sens. Marco Rubio (R-FL) and Kyrsten Sinema (D-AZ) — urged the agency to reconsider its proposed changes to Medicare’s six protected classes policy. The Senators emphasized that the protected classes serve as an essential patient safeguard for beneficiaries with complex medical conditions, noting that the policy has long enjoyed bipartisan support among lawmakers. “The proposed rule would allow Part D plans to limit access to critical medicines to patients in need of immunosuppressants, antidepressants, antipsychotics, anticonvulsants, antiretrovirals, and antineoplastic medicines, by permitting prior authorization or step therapy,” the letter states. “We urge CMS to reconsider this proposal that would risk the health of our most vulnerable beneficiaries.

The letter in its entirety can accessed below. 

rubio-sinema_protected_classes_leter.pdf
File Size: 623 kb
File Type: pdf
Download File

1 Comment
Hailey Garcia
6/8/2024 10:03:06 am

My name is Hailey Garcia and I am from New Jersey. My herpes virus turned to war after 2 years of living with it. I have tried different medical procedures to cure my herpes but to no avail. Most people think herpes is only a minor skin irritation of which herpes has long term effects on health and passes through the bloodstream and can be easily contracted through sexual intercourse. I knew I had herpes from the first day I started feeling itchy in my pubic area and the pain was very unbearable. I couldn't stand it anymore. After 2 years of trying other means to get rid of it, I had to contact Doctor Odunga to help me with a permanent cure. I saw his email and whats-app number from a testimony I read online from a lady who was also helped by him in curing infertility problems, I had faith and contacted him. He assured me of his work and I ordered his herbal medicine. Within 5 days, I didn't feel any pain anymore and within 2 weeks, my skin was all cleared and smooth. I am very grateful to you sir and I write this testimony as others have done to bring those having faith to you sir. If you have herpes or other similar disease and you want it cured, kindly contact Doctor Odunga, Whats-App (wa.me/+2348167159012) OR Email [email protected]


🛑 PERMANENT SOLUTION FOR TREATMENT, CURE & PREVENTION OF THE FOLLOWING :❗❗

🛑Kidney Failures
🛑 Osteoporosis
🛑 TB
🛑Sexual Dysfunction
🛑Period Pain
🛑 Dementia
🛑 Parkinson's
🛑Infertility
🛑ProstateEnlargement
🛑 Libido
🛑Fibroids/Cysts
🛑 Epilepsy
🛑Stroke
🛑Cancer
🛑 Burns
🛑HIV

Reply

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    September 2023
    September 2022
    November 2021
    March 2021
    February 2021
    January 2021
    November 2020
    January 2020
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    April 2018
    March 2018
    September 2017
    May 2017
    April 2017
    November 2016
    July 2016

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.